Patents Assigned to BioMediCan, Inc.
  • Production of cannabinoids in yeast
    Patent number: 11939613
    Abstract: The present disclosure relates to the production of cannabinoids in yeast. In as aspect there is provided a genetically modified yeast comprising: one or more GPP producing genes and optionally, one or more GPP pathway genes; two or more olivetolic acid producing genes; one or more cannabinoid precursor or cannabinoid producing genes; one or more Hexanoyl-CoA producing genes, and at least 5% dry weight of fatty acids or fats.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: March 26, 2024
    Assignee: BIOMEDICAN, INC.
    Inventors: Maxim Mikheev, Difeng Gao
  • 3D PRINTER
    Publication number: 20220016840
    Abstract: A 3D printer comprising an extruder comprising a heated nozzle for depositing a layer of molten material on to a substrate, and a heating means configured to heat the substrate in an area underneath the heated nozzle of the extruder.
    Type: Application
    Filed: December 11, 2019
    Publication date: January 20, 2022
    Applicant: BioMediCan, Inc.
    Inventor: Maxim Mikheev
  • Production of cannabinoids in yeast
    Patent number: 11149291
    Abstract: The present disclosure relates to the production of cannabinoids in yeast. In as aspect there is provided a genetically modified yeast comprising: one or more GPP producing genes and optionally, one or more GPP pathway genes; two or more olivetolic acid producing genes; one or more cannabinoid precursor or cannabinoid producing genes; one or more Hexanoyl-CoA producing genes, and at least 5% dry weight of fatty acids or fats.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: October 19, 2021
    Assignee: BioMediCan, Inc.
    Inventors: Maxim Mikheev, Difeng Gao
  • PRODUCTION OF CANNABINOIDS IN YEAST
    Publication number: 20200165644
    Abstract: The present disclosure relates to the production of cannabinoids in yeast. In as aspect there is provided a genetically modified yeast comprising: one or more GPP producing genes and optionally, one or more GPP pathway genes; two or more olivetolic acid producing genes; one or more cannabinoid precursor or cannabinoid producing genes; one or more Hexanoyl-CoA producing genes, and at least 5% dry weight of fatty acids or fats.
    Type: Application
    Filed: July 12, 2018
    Publication date: May 28, 2020
    Applicant: BioMediCan, Inc.
    Inventors: Maxim Mikheev, Difeng Gao